Skip to main content

Table 1 Novel RNAi hypersensitive strains and gene-dependent hypersensitivity

From: Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity

  

N2

rrf-3 (pk1426)

lin-35 (n2239)

lin-37 (n758)

zfp-2 (tm557)

RNAi

Phenotype

     

gpc-2

Emb

0%

14.9%

2.6%

2.8%

0%

mom-2

Emb

17.8%

40.1%

64.1%

67.4%

69.4%

hmr-1

Lvl

0%

Ste, Ooc, Emb

80.7%

77.6%

53.1%

cel-1

Lva

0.5%

100%

98.6%

11%*

23.2%

unc-87

Unc

3.6%

0%

94.2%

85.3%

0%

unc-15

Unc

0%

100%

96.5%

92.6%

0%

  1. We tested several RNAi clones, previously used by others to quantitatively examine sensitivity to RNAi, in different genetic backgrounds [26,62,63]. To allow comparison with RNAi effects reported by others, we used RNAi clones from the Ahringer Library [64] except for cel-1(Vidal library). Numbers are averages of 3 to 6 experiments and indicate proportion of animals (F1 progeny) displaying the corresponding phenotype. In agreement with recent findings [26,65], we also observed that different RNAi hypersensitive mutants showed surprising gene specificity in RNAi enhancement.
  2. *cel-1 RNAi in lin-37(n758) produces larval arrest at later stages